It’s a new way to create “bi-paternal” mice that can survive to adulthood—but human applications are still a long way off.

This new tool, known as minimal, versatile genetic perturbation technology (mvGPT), combines the powers of gene editing, ...

Researchers using CRISPR-Cas9 gene editing tools have discovered that while this technology can enhance T cell cancer therapies, it may also lead to unintended chromosomal loss in the edited immune ...

After that, the next step in CRISPR gene editing is usually to alter that piece of DNA. However, CRISPR has also been adapted to do other things too, such as turning genes on or off without ...

But CRISPR's use isn't limited to only genetic diseases. Several gene-editing companies are also targeting various types of cancer. In particular, CRISPR is being used to develop chimeric antigen ...

In this installment, we delve into one of the most debated scientific advancements of our time: CRISPR gene-editing ...

CRISPR-Cas9 genome editing ... diseases using heritable genome editing. Scientists argue that the technology involves considerable risk and uncertain benefits. Gene drive alleles bias their ...

In July 2023, Sanofi expanded an existing partnership with Scribe Therapeutics to use its CRISPR-based gene-editing technology to develop both in vivo and ex vivo cancer cell therapies.

CRISPR gene-editing technology presents a possible solution for feeding a growing population, but incorporating CRISPR into ...

CRISPR Therapeutics AG (NASDAQ:CRSP), a leading biotechnology company specializing in gene-based medicines with a market capitalization of $3.45 billion, stands at a critical juncture as it navigates ...